Showing results (51-60 of 133) with videos related to
Sort By:
Pageof 14
CNS Drugs|December 23, 2017
Assessing 'No Evidence of Disease Activity' Status in Patients with Relapsing-Remitting Multiple Sclerosis Receiving Fingolimod in Routine Clinical Practice: A Retrospective Analysis of the Multiple Sclerosis Clinical and Magnetic Resonance Imaging Outcomes in the USA (MS-MRIUS) StudyBianca Weinstock-Guttman, Jennie Medin, Nasreen Khan, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 6, 2021
Confirmed disability progression provides limited predictive information regarding future disease progression in multiple sclerosisBrian C Healy, Bonnie I Glanz, Elyse Swallow, et al.Water Science and Technology : a Journal of the International Association on Water Pollution Research|November 7, 2012
Adsorption of leather dye onto activated carbon prepared from bottle gourd: equilibrium, kinetic and mechanism studiesEdson Luiz Foletto, Caroline Trevisan Weber, Diego Silva Paz, et al.Journal of Neurology, Neurosurgery, and Psychiatry|July 28, 2022
Thalamic atrophy measured by artificial intelligence in a multicentre clinical routine real-word study is associated with disability progressionRobert Zivadinov, Niels Bergsland, Dejan Jakimovski, et al.The Cochrane Database of Systematic Reviews|February 12, 2025
Graded activity for chronic low back painLisandra Almeida de Oliveira, Anita R Gross, Lisa Carlesso, et al.Sustainability Science|February 22, 2021
EMF 35 JMIP study for Japan's long-term climate and energy policy: scenario designs and key findingsMasahiro Sugiyama, Shinichiro Fujimori, Kenichi Wada, et al.The Cochrane Database of Systematic Reviews|January 27, 2025
Graded activity for acute and subacute low back painLisandra Almeida de Oliveira, Anita R Gross, Jill A Hayden, et al.Current Medical Research and Opinion|April 13, 2018
No evidence of disease activity in patients receiving fingolimod at private or academic centers in clinical practice: a retrospective analysis of the multiple sclerosis, clinical, and magnetic resonance imaging outcomes in the USA (MS-MRIUS) studyRobert Zivadinov, Nasreen Khan, Jonathan R Korn, et al.Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|July 2, 2019
Salient Central Lesion Volume: A Standardized Novel Fully Automated Proxy for Brain FLAIR Lesion Volume in Multiple SclerosisMichael G Dwyer, Niels Bergsland, Deepa P Ramasamy, et al.BMJ Open|January 16, 2016
Using a Delphi process to define priorities for prison health research in CanadaFiona G Kouyoumdjian, Andrée Schuler, Kathryn E McIsaac, et al.Pageof 14